Telomeres and telomerase in aging, regeneration and cancer

Molecules and Cells

Volumn 15, Issue 2, 2003, Pages 164-175

  Djojosubroto, Meta Wulandari ^a   Choi, Yoon Sik ^b   Lee, Han Woong ^b   Rudolph, Karl Lenhard ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

^b Sungkyunkwan University School of Medicine   (South Korea)

Author keywords

Aging; Chronic Disease; Regeneration; Telomerase Therapy; Telomere Shortening

Indexed keywords

TELOMERASE;

AGING; CANCER INHIBITION; CARCINOGENESIS; CELL DIVISION; CELL SURVIVAL; CHROMOSOMAL INSTABILITY; CHRONIC DISEASE; DNA DAMAGE; ENZYME ACTIVATION; ENZYME DEFICIENCY; ENZYME REACTIVATION; HUMAN; IN VIVO STUDY; MALIGNANT NEOPLASTIC DISEASE; NONHUMAN; SHORT SURVEY; TELOMERE; TISSUE REGENERATION; ANIMAL; APOPTOSIS; GENETICS; METABOLISM; MOUSE; NEOPLASM; PHYSIOLOGY; REGENERATION; REVIEW;

ANIMALS; APOPTOSIS; HUMANS; MICE; NEOPLASMS; REGENERATION; TELOMERASE; TELOMERE;

EID: 0037928721     PISSN: 10168478     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Short Survey

References (129)

1. Adelfalk, C., Lorenz, M., Serra, V., von Zglinicki, T., Hirsch-Kauffmann, M., and Schweiger, M. (2001) Accelerated telomere shortening in Fanconi anemia fibroblasts - a longitudinal study. FEBS Lett. 506, 22-26.
2. Aikata, H., Takaishi, H., Kawakami, Y., Takahashi, S., Kitamoto, M., Nakanishi, T., Nakamura, Y., Shimamoto, F., Kajiyama, G., and Ide, T. (2000) Telomere reduction in human liver tissues with age and chronic liver inflammation. Exp. Cell. Res. 256, 578-582.
3. Allsopp, R. C., Vaziri, H., Patterson, C., Goldstein, S., Younglai, E. V., Futcher, A. B., Greider, C. W., and Harley, C. B. (1992) Telomere length predicts replicative capacity of human fibroblast. Proc. Natl. Acad. Sci. USA 89, 10114-10118.
4. Allsopp, R. C., Chang, E., Kashefi-Aazam, M., Rogaev, E. I., Piatyszek, M. A., Shay, J. W., and Harley, C. B. (1995) Telomere shortening is associated with cell division in vitro and in vivo. Exp. Cell. Res. 220, 194-200.
5. Artandi, S. E., Chang, S., Lee, S. L., Alson, S., Gottlieb, G. J., Chin, L., and DePinho, R. A. (2000) Telomere dysfunction promotes non-reciprocal translocation and epithelial cancers in mice. Nature 406, 641-645.
6. Artandi, S. E., Alson, S., Tietze, M. K., Sharpless, N. E., Ye, S., Greenberg, R. A., Castrillon, D. H., Horner, J. W., Weiler, S. R., Carrasco, R. D., and DePinho, R. A. (2002) Constitutive telomerase expression promotes mammary carcinomas in aging mice. Proc. Natl. Acad. Sci. USA 99, 8191-8196.
7. Artlett, C. M., Black, C. M., Briggs, D. C., Stevens, C. O., and Welsh, K. I. (1996) Telomere reduction in scleroderma patients: a possible cause for chromosomal instability. Br. J. Rheumatol. 35, 732-737.
8. Ball, S. E., Gibson, F. M., Rizzo, S., Tooze, J. A., Marsh, J. C., and Gordon-Smith, E. C. (1998) Progressive telomere shortening in aplastic anemia. Blood 91, 3582-3592.
9. Blackburn, E. H. (1991) Structure and function of telomeres. Nature 350, 569-573.
10. Blasco, M. A., Funk, W., Villeponteau, B., and Greider, C. W. (1995) Functional characterization and developmental regulation of mouse telomerase RNA. Science 269, 1267-1270.
11. Blasco, M. A., Lee, H.-W., Hande, M. P., Samper, E., Lansdorp, P. M., DePinho, R. A., and Greider, C. W. (1997) Telomere shortening and tumor formation by mouse cells lacking telomerase RNA. Cell 91, 25-34.
12. Bodnar, A. G., Oullette, M., Frolkis, M., Holt, S. E., Chiu, C.-P., Morin, G. B., Harley, C. B., Shay, J. W., Lichtsteiner, S., and Wright, W. E. (1998) Extension of life-span by introduction of telomerase into normal human cells. Science 279, 349-352.
13. Boultwood, J., Fidler, C., Shepherd, P., Watkins, F., Snowball, J., Haynes, S., Kusec, R., Gaiger, A., Littlewood, T. J., Peniket, A. J., and Wainscoat, J. S. (1999) Telomere length shortening is associated with disease evolution in chronic myelogenous leukemia. Am. J. Hematol. 61, 5-9.
14. Brummendorf, T. H., Holyoake, T. L., Rufer, N., Barnett, M. J., Schulzer, M., Eaves, C. J., Eaves, A. C., and Lansdorp, P. M. (2000) Prognostic implications of differences in telomere length between normal and malignant cells from patients with chronic myeloid leukemia measured by flow cytometry. Blood 95, 1883-1890.
15. Brummendorf, T. H., Rufer, N., Holyoake,.T. L., Maciejewski, J., Barnett, M. J., Eaves, C. J., Eaves, A. C., Young, N., and Lansdorp, P. M. (2001) Telomere length dynamics in normal individuals and in patients with hematopoietic stem cell-associated disorders. Ann. NY. Acad. Sci. 938, 293-303.
16. Bryan, T. M., Englezou, A., Gupta, J., Bacchetti, S., and Reddel, R. R. (1995) Telomere elongation in immortal human cells without detectable telomerase activity. EMBO J. 14, 4240-4248.
17. Burger, A. M., Bibby, M. C., and Double, J. A. (1997) Telomtivity. Cancer Res. 61, 7594-7602.
18. Engelhardt, M., Drullinsky, P., Guillem, J., and Moore, M. A. (1997a) Telomerase and telomere length in the development and progression of premalignant lesions to colorectal cancer. Clin. Cancer Res. 3, 1931-1941.
19. Engelhardt, M., Kumar, R., Albanell, J., Pettengell, R., Han, W., and Moore, M. A. (1997b) Telomerase regulation, cell cycle, and telomerase stability in primitive hematopoietic cells. Blood 90, 182-193.
20. Espejel, S., Franco, S., Rodriguez-Perales, S., Bouffler, S. D., Cigudosa, J. C., and Blasco, M. A. (2002) Mammalian Ku86 mediates chromosomal fusions and apoptosis caused by critically short telomeres. EMBO J. 21, 2207-2219.
21. Feng, J., Funk, W. D., Wang, S. S., Weinrich, S. L., Avilion, A. A., Chiu, C. P., Adams, R. R., Chang, E., Allsopp, R. C., Yu, J., Le, S., West, M. D., Harley, C. B., Andrews, W. H., Greider, C. W., and Villeponteau, B. (1995) The RNA component of human telomerase. Science 269, 1236-1241.
22. Feng, Y. R., Biggar, R. J., Gee, D., Norwood, D., Zeichner, S. L., and Dimitrov, D. S. (1999) Long-term telomere dynamics: modest increase of cell turnover in HIV-infected individuals followed for up to 14 years. Pathobiology 67, 34-38.
23. Franco, S., Segura, I., Riese, H. H., and Blasco, M. A. (2002) Decreased B16F10 melanoma growth and impaired vascularization in telomerase-deficient mice with critically short telomeres. Cancer Res. 62, 552-559.
24. Frenck, R. W., Blackburn, E. H., and Shannon, K. M. (1998) The rate of telomere sequence loss in human leukocytes varies with age. Proc. Natl. Acad. Sci. USA 95, 5607-5610.
25. Furugori, E., Hirayama, R., Nakamura, K. I., Kammori, M., Esaki, Y., and Takubo, K. (2000) Telomere shortening in gastric carcinoma with aging despite telomerase activation. J. Cancer Res. Clin. Oncol. 216, 481-485.
26. Gonzalez-Suarez, E., Samper, E., Flores, J. M., and Blasco, M. A. (2000) Telomerase-deficient mice with short telomeres are resistant to skin tumorigenesis. Nat. Genet. 26, 114-117.
27. Greenberg, R. A., Allsopp, R. C., Chin, L., Morin, G. B., and DePinho, R. A. (1998) Expression of mouse telomerase reverse transcriptase during development, differentiation and proliferation. Oncogene 16, 1723-1730.
28. Greenberg, R. A., O'Hagan, R. C., Deng, H., Xiao, Q., Hann, S. R., Adams, R. R., Lichtsteiner, S., Chin, L., Morin, G. B., and DePinho, R. A. (1999a) Telomerase reverse transcriptase gene is a direct target of c-Myc but is not functionally equivalent in cellular transformation. Oncogene 18, 1219-1226.
29. Greenberg, R. A., Chin, L., Femino, A., Lee, K. H., Gottlieb, G. J., Singer, R. H., Greider, C. W., and DePinho, R. A. (1999b) Short dysfunctional telomeres impair tumorigenesis in the INK4a(delta2/3) cancer-prone mouse. Cell 97, 515-525.
30. Greider, C. W. and Blackburn, E. H. (1985) Identification of a specific telomere terminal transferase activity in Tetrahymena extracts. Cell 43, 405-413.
31. Hande, P., Samper, E., Lansdorp, P., and Blasco, M. A. (1999) Telomere length dynamics and chromosomal instability in cells derived from telomerase null mice. J. Cell Biol. 144, 589-601.
32. Harle-Bachor, C. and Boukamp, P. (1996) Telomerase activity in the regenerative basal layer of the epidermis in human skin and in immortal and carcinoma-derived skin keratinocytes. Proc. Natl. Acad. Sci. USA 93, 6476-6481.
33. Harley, C. B., Futcher, A. B., and Greider, C. W. (1990) Telomeres shorten during ageing of human fibroblasts. Nature 345, 458-460.
34. Heiss, N. S., Knight, S. W., Vulliamy, T. J., Klauck, S. M., Wiemann, S., Mason, P. J., Poustka, A., and Dokal, I. (1998) X-linked dyskeratosis congenita is caused by mutations in a highly conserved gene with putative nucleolar functions. Nat. Genet. 19, 32-38.
35. Hemann, M. T., Strong, M. A., Hao, L. Y., and Greider, C. W. (2001) The shortest telomere, not average telomere length, is critical for cell viability and chromosome stability. Cell 107, 67-77.
36. Herbert, B.-S., Wright, W. E., and Shay, J. W. (2002) p16(INK4a) inactivation is not required to immortalize human mammary epithelial cells. Oncogene 21, 7897-7900.
37. Herrera, E., Samper, E., and Blasco, M. A. (1999a) Telomere shortening in mTR-/- embryos is associated with failure to close the neural tube. EMBO J. 18, 1172-1181.
38. Herrera, E., Samper, E., Martin-Caballero, J., Flores, J. M., Lee, H.-W., and Blasco, M. A. (1999b) Disease states associated with telomerase deficiency appear earlier in mice with short telomeres. EMBO J. 18, 2950-2960.
39. Hiyama, K., Hirai, Y., Kyoizumi, S., Akiyama, M., Piatyszek, M. A., Shay, J. W., Ishioka, S., and Yamakido, M. (1995) Activation of telomerase in human lympocytes and hematopoietic progenitor cells. J. Immunol. 155, 3711-3715.
40. Hiyama, E., Hiyama, K., Yokoyama, T., and Shay, J. W. (2001) Immunohistochemical detection of telomerase (hTERT) protein in human cancer tissues and a subset of cells in normal tissues. Neoplasia 3, 17-26.
41. Hodes, R. J., Hathcock, K. S., and Weng, N. P. (2002) Telomeres in T and B cells. Nat. Rev. Immunol. 2, 699-706.
42. Honda, M., Mengesha, E., Albano, S., Nichols, W. S., Wallace, D. J., Metzger, A., Klinenberg, J. R., and Linker-Israeli, M. (2001) Telomere shortening and decreased replicative potential, contrasted by continued proliferation of telomerase-positive CD8+CD28(lo) T cells in patients with systemic lupus erythematosus. Clin. Immunol. 99, 211-221.
43. Ito, H., Kyo, S., Kanaya, T., Takakura, M., Inoue, M., and Namiki, M. (1998) Expression of human telomerase subunits and correlation with telomerase activity in urothelial cancer. Clin. Cancer Res. 4, 1603-1608.
44. Jiang, X. R., Jimenez, G., Chang, E., Frolkis, M., Kusler, B., Sage, M., Beeche, M., Bodnar, A. G., Wahl, G. M., Tisty, T. D., and Chiu, C.-P. (1999) Telomerase expression in human somatic cells does not induce changes associated with a transformed phenotype. Nat. Genet. 21, 111-114.
45. Johnson, F. B., Marciniak, R. A., McVey, M., Stewart, S. A., Hahn, W. C., and Guarente, L. (2001) The Saccharomyces cerevisiae WRN homolog Sgs1p participates in telomere maintenance in cells lacking telomerase. EMBO J. 20, 905-913.
46. Kanaya, T., Kyo, S., Takakura, M., Ito, H., Namiki, M., and Inoue, M. (1998) hTERT is a critical determinant of telomerase activity in renal-cell carcinoma. Int. J. Cancer 78, 539-543.
47. Kang, M. K., Swee, J., Kim, R. H., Baluda, M. A., and Park, N. H. (2002) The telomeric length and heterogeneity decrease with age in normal human oral keratinocytes. Mech. Ageing Dev. 123, 585-592.
48. Katoh, M., Katoh, M., Kameyama, M., Kugoh, H., Shimizu, M., and Oshimura, M. (1998) A repressor function for telomerase activity in telomerase-negative immortal cells. Mol. Carcinog. 21, 17-25.
49. Kim, N. W., Piatyszek, M. A., Prowse, K. R., Harley, C. B., West, M. D., Ho, P. L. C., Coviello, G. M., Wright, W. E., Weinrich, S. L., and Shay, J. W. (1994) Specific association of human telomerase activity with immortal cells and cancer. Science 266, 2011-2015.
50. Kinouchi, Y., Hiwatashi, N., Chida, M., Nagashima, F., Takagi, S., Maekawa, H., and Toyota, T. (1998) Telomere shortening in the colonic mucosa of patients with ulcerative colitis. J. Gastroenterol. 33, 343-348.
51. Kitada, T., Seki, S., Kawakita, N., Kuroki, K., and Monna, T. (1995) Telomere shortening in chronic liver diseases. Biochem. Biophys. Res. Commun. 211, 33-39.
52. Kiyono, T., Foster, S. A., Koop, J. I., McDougall, J. K., Galloway, D. A., and Klingelhutz, A. J. (1998) Both Rb/p16INK4a inactivation and telomerase activity are required to immortalize human epithelial cells. Nature 396, 84-88.
53. Kugoh, H., Shigenami, K., Funaki, K., Barrett, J. C., and Oshimura, M. (2003) Human chromosome 5 carries a putative telomerase repressor gene. Genes Chromosomes Cancer 36, 37-47.
54. Kyo, S., Kanaya, T., Takakura, M., Tanaka, M., and Inoue, M. (1999) Human telomerase reverse transcriptase as a critical determinant of telomerase activity in normal and malignant endometrial tissues. Int. J. Cancer 80, 60-63.
55. Lee, H.-W., Blasco, M. A., Gottlieb, G. J., Horner, J. W., Greider, C. W., and DePinho, R. A. (1998) Essential role of mouse telomerase in highly proliferative organs. Nature 392, 569-574.
56. Li, X., Leteurtre, F., Rocha, V., Guardiola, P., Berger, R., Daniel, M. T., Noguera, M. H., Maarek, O., Roux, G. L., De La Salmoniere, P., Richard, P., and Gluckman, E. (2003) Abnormal telomere metabolism in Fanconi's anaemia correlates with genomic instability and the probability of developing severe aplastic anaemia. Br. J. Haematol. 20, 836-845.
57. Maini, M. K., Soares, M. V., Zilch, C. F., Akbar, A. N., and Beverley, P. C. (1999) Virus-induced CD8+ T cell clonal expansion is associated with telomerase up-regulation and telomere length preservation: a mechanism for rescue from replicative senescence. J. Immunol. 162, 4521-4526.
58. Martens, U. M., Brass, V., Sedlacek, L., Pantic, M., Exner, C., Guo, Y., Engelhardt, M., Lansdorp, P. M., Waller, C. F., and Lange, W. (2002) Telomere maintenance in human B lymphocytes. Br. J. Haematol. 119, 810-818.
59. Martin, J. A. and Buckwalter, J. A. (2002) Human chondrocyte senescence and osteoarthritis. Biorheology 39, 145-152.
60. Martin-Rivera, L., Herrera, E., Albar, J. P., and Blasco, M. A. (1998) Expression of mouse telomerase catalytic subunit in embryos and adult tissues. Proc. Natl. Acad. Sci. USA 95, 10471-10476.
61. Meeker, A. K., Hicks, J. L., Platz, E. A., March, G. E., Bennett, C. J., Delannoy, M. J., and De Marzo, A. M. (2002) Telomere shortening is an early somatic DNA alteration in human prostate tumorigenesis. Cancer Res. 62, 6405-6409.
62. Melk, A., Ramassar, V., Helms, L. M., Moore, R., Rayner, D., Solez, K., and Halloran, P. F. (2000) Telomere shortening in kidneys with age. J. Am. Soc. Nephrol. 11, 444-453.
63. Metcalfe, J. A., Parkhill, J., Campbell, L., Stacey, M., Biggs, P., Byrd, P. J., and Taylor, A. M. (1996) Accelerated telomere shortening in ataxia telangiectasia. Nat. Genet. 13, 350-353.
64. Meyerson, M., Counter, C. M., Eaton, E. N., Ellisen, L. W., Steiner, P., Caddle, S. D., Ziaugra, L., Beijersbergen, R. L., Davidoff, M. J., Liu, Q., Bacchetti, S., Haber, D. A., and Weinberg, R. A. (1997) hEST2, the putative human telomerase catalytic subunit gene, is up-regulated in tumor cells and during immortalization. Cell 90, 785-795.
65. Minamino, T., Miyauchi, H., Yoshida, T., Ishida, Y., Yoshida, H., and Komuro, I. (2002) Endothelial cell senescence in human atherosclerosis: role of telomere in endothelial dysfunction. Circulation 105, 1541-1544.
66. Mitchell, J. R., Wood, E., and Collins, K. (1999) A telomerase component is defective in the human disease dyskeratosis congenita. Nature 402, 551-555.
67. Miura, N., Horikawa, I., Nishimoto, A., Ohmura, H., Ito, H., Hirohashi, S., Shay, J. W., and Oshimura, M. (1997) Progressive telomere shortening and telomere reactivation during hepatocellular carcinogcncsis. Cancer Genet. Cytogenet. 93, 56-62.
68. Morales, C. P., Holt, S. E., Oullette, M., Kaur, K. J., Yan, Y., Wilson, K. S., White, M. A., Wright, W. E., and Shay, J. W. (1999) Absence of cancer-associated changes in human fibroblasts immortalized with telomerase. Nat. Genet. 21, 115-118.
69. Morin, G. B. (1989) The human telomerase terminal transferase enzyme is a ribonucleoprotein that synthesizes TTAGGG repeats. Cell 59, 521-529.
70. Moyzis, R. K., Buckingham, J. M., Cram, L. S., Dani, M., Deaven, L. L., Jones, M. D., Meyne, J., Ratliff, R. L., and Wu, J.-R. (1988) A highly conserved repetitive DNA sequence, (TTAGGG)n, present at the telomeres of human chromosomes. Proc. Natl. Acad. Sci. USA 85, 6622-6626.
71. Nakamura, T. M., Morin, G. B., Chapman, K. B., Weinrich, S. L., Andrews, W. H., Lingner, J., Harley, C. B., and Cech, T. R. (1997) Telomerase catalytic subunit homologs from fission yeast and human. Science 277, 955-959.
72. Nakamura, H., Fukami, H., Hayashi, Y., Kiyono, T., Nakatsugawa, S., Hamaguchi, M., and Ishizaki, K. (2002) Establishment of immortal normal and ataxia telangiectasia fibroblast cell lines by introduction of the hTERT gene. J. Radiat. Res. 43, 167-174.
73. Nishimoto, A., Miura, N., Horikawa, I., Kugoh, H., Murakami, Y., Hirohashi, S., Kawasaki, H., Gazdar, A. F., Shay, J. W., Barrett, J. C., and Oshimura, M. (2001) Functional evidence for a telomerase repressor gene on human chromosome 10p15.1. Oncogene 20, 828-835.
74. Norrback, K. F., Hultdin, M., Dahlenborg, K., Osterman, P., Carlsson, R., and Roos, G. (2001) Telomerase regulation and telomere dynamics in germinal centers. Eur. J. Haematol. 67, 309-317.
75. Nugent, C. I. and Lundbland, V. (1998) The telomerase reverse transcriptase: components and regulations. Genes Dev. 12, 1073-1085.
76. Oexle, K. and Zwirner, A. (1997) Advanced telomere shortening in respiratory chain disorders. Hum. Mol. Genet. 6, 905-908.
77. Ohashi, K., Tsutsumi, M., Nakajima, Y., Kobitsu, K., Nakano, H., and Konishi, Y. (1996a) Telomere changes in human hepatocellular carcinomas and hepatitis virus infected noncancerous livers. Concern, 1747-1751.
78. Ohashi, K., Tsutsumi, M., Kobitsu, K., Fukuda, T., Tsujiuchi, T., Okajima, E., Ko, S., Nakajima, Y., Nakano, H., and Konishi, Y. (1996b) Shortened telomere length in hepatocellular carcinoma and corresponding background liver tissues of patients infected with hepatitis virus. Jpn. J. Cancer Res. 87, 419-422.
79. Ohtsuka, T., Yamakage, A., and Yamazaki, S. (2002) The polymorphism of telomerase RNA component gene in patients with systemic sclerosis. Br. J. Dermatol. 147, 250-254.
80. Ohyashiki, J. H., Ohyashiki, K., Fujimura, T., Kawakubo, K., Shimamoto, T., Iwabuchi, A., and Toyama, K. (1994) Telomere shortening associated with disease evolution patterns in myelodysplastic syndromes. Cancer Res. 54, 3557-3560.
81. Opresko, P. L., von Kobbe, C., Laine, J. P., Harrigan, J., Hickson, I. D., and Bohr, V. A. (2002) Telomere-binding protein TRF2 binds to and stimulates the Werner and Bloom syndrome helicases. J. Biol. Chem. 277, 41110-41119.
82. Paradis, V., Youssef, N., Dargere, D., Ba, N., Bonvoust, F., Deschatrette, J., and Bedossa, P. (2001) Replicative senescence in normal liver, chronic hepatitis C, and hepatocellular carcinomas. Hum. Pathol. 32, 327-332.
83. Prowse, K. R. and Greider, C. W. (1995) Developmental and tissue-specific regulation of mouse telomerase and telomere length. Proc. Natl. Acad. Sci. USA 92, 4818-4822.
84. Ramirez, R., Carracedo, J., Jimenez, R., Canela, A., Herrera, E., Aljama, P., and Blasco, M. A. (2003) Massive telomere loss is an early event of DNA damage-induced apoptosis. J. Biol. Chem. 278, 836-842.
85. Remes, K., Norrback, K. F., Rosenquist, R., Mehle, C., Lindh, J., and Roos, G. (2000) Telomere length and telomerase activity in malignant lymphomas at diagnosis and relapse. Br. J. Cancer 82, 601-607.
86. Ren, J. G., Xia, H. L., Just, T., and Dai, Y. R. (2001) Hydroxyl radical-induced apoptosis in human tumor cells is associated with telomere shortening but not telomerase inhibition and caspase activation. FEBS Lett. 488, 123-132.
87. Richardson, M. W., Sverstiuk, A., Hendel, H., Cheung, T. W., Zagury, J. F., and Rappaport, J. (2000) Analysis of telomere length and thymic output in fast and slow/non-progressor with HIV infection. Biomed. Pharmacother. 54, 21-31.
88. Rudolph, K. L. and DePinho, R. A. (2001) Telomeres and telomerase in experimental liver cirrhosis; in The Liver: Biology and Pathology, Arias, I. M., Boyer, J. L., Chisari, F. V., Fausto, N., Schachter, D., and Shafritz, D. (eds.), 4th ed., pp. 1000-1010, Lippincott Williams and Wilkins, Philadelphia.
89. Rudolph, K. L., Chang, S., Lee, H.-W., Blasco, M., Gottlieb, G. J., Greider, C., and DePinho, R. A. (1999) Longevity, stress response, and cancer in aging telomerase-deficient mice. Cell 96, 701-712.
90. Rudolph, K. L., Chang, S., Millard, M., Schreiber-Agus, N., and DePinho, R. A. (2000) Inhibition of experimental liver cirrhosis in mice by telomerase gene delivery. Science 287, 1253-1258.
91. Rudolph, K. L., Millard, M., Bosenberg, M. W., and DePinho, R. A. (2001) Telomere dysfunction and evolution of intestinal carcinoma in mice and humans. Nat. Genet. 28, 155-159.
92. Samani, N. J., Boultby, R., Butler, R., Thompson, J. R., and Goodall, A. H. (2001) Telomere shortening in atherosclerosis. Lancet 358, 472-473.
93. Samper, E., Goytisolo, F. A., Slijepcevic, P., van Buul, P. P., and Blasco, M. A. (2000) Mammalian Ku86 protein prevents telomeric fusions independently of the length of TTAGGG repeats and the G-strand overhang. EMBO Rep. 1, 244-252.
94. Saretzki, G. and Von Zglinicki, T. (2002) Replicative aging, telomeres, and oxidative stress. Ann. NY. Acad. Sci. 959, 24-29.
95. Satoh, H., Hiyama, K., Takeda, M., Awaya, Y., Watanabe, K., Ihara, Y., Maeda, H., Ishioka, S., and Yamakido, M. (1996) Telomere shortening in peripheral blood cells was related with aging but not with white blood cell count. Jpn. J. Hum. Genet. 41, 413-417.
96. Schindler, D. and Hoehn, H. (1988) Fanconi anemia mutation causes cellular susceptibility to ambient oxygen. Am. J. Hum. Genet. 43, 429-435.
97. Schnabl, B., Choi, Y. H., Olsen, J. C., Hagedorn, C. H., and Brenner, D. A. (2002) Immortal activated human hepatic stellate cells generated by ectopic telomerase expression. Lab. Invest. 82, 323-333.
98. Schulz, V. P., Zakian, V. A., Ogburn, C. E., McKay, J., Jarzebowicz, A. A., Edland, S. D., and Martin, G. M. (1996) Accelerated loss of telomeric repeats may not explain accelerated replicative decline of Werner syndrome cells. Hum. Genet. 97, 750-754.
99. Sharpless, N. E. and DePinho, R. A. (2002) p53: good cop/bad cop. Cell 12, 9-12.
100. Shay, J. W. and Bacchetti, S. (1997) A survey of telomerase activity in human cancer. Eur. J. Cancer 33, 787-791.
101. Slagboom, P. E., Droog, S., and Boomsma, D. I. (1994) Genetic determination of telomere size in humans: a twin study of three age groups. Am. J. Hum. Genet. 55, 876-882.
102. Smogorzewska, A. and de Lange, T. (2002) Different telomere damage signaling pathways in human and mouse cells. EMBO J. 21, 4338-4348.
103. Surralles, J., Hande, M. P., Marcos, R., and Lansdorp, P. M. (1999) Accelerated telomere shortening in the human inactive X chromosome. Am. J. Hum. Genet. 65, 1617-1622.
104. Takakura, M., Kyo, S., Kanaya, T., Tanaka, M., and Inoue, M. (1998) Expression of human telomerase subunits and correlation with telomerase activity in cervical cancer. Cancer Res. 58, 1558-1561.
105. Takubo, K., Nakamura, K., Izumiyama, N., Furugori, E., Sawabe, M., Arai, T., Esaki, Y., Mafune, K., Kammori, M., Fujiwara, M., Kato, M., Oshimura, M., and Sasajima, K. (2000) Telomere shortening with aging in human liver. J. Gerontol. A. Biol. Sci. Med. Sci. 55, B533-536.
106. Takubo, K., Izumiyama-Shimomura, N., Honma, N., Sawabe, M., Arai, T., Kato, M., Oshimura, M., and Nakamura, K. (2002) Telomere length are characteristic in each human individual. Exp. Gerontol. 37, 523-531.
107. Tian, X. C., Xu, J., and Yang, X. (2000) Normal telomere lengths found in cloned cattle. Nat. Genet. 26, 272-273.
108. Tsutsui, T., Kumakura, S., Yamamoto, A., Kanai, H., Tamura, Y., Kato, T., Anpo, M., Tahara, H., and Barrett, J. C. (2002) Association of p16(INK4a) and pRb inactivation with immortalization of human cells. Carcinogenesis 23, 2111-2117.
109. Urabe, Y., Nouso, K., Higashi, T., Nakatsukasa, H., Hino, N., Ashida, K., Kinugasa, N., Uematso, S., and Tsuji, T. (1996) Telomere length in human liver diseases. Liver 16, 293-297.
110. Vaziri, H., Schachter, F., Uchida, I., Wei, L., Zhu, X., Effros, R., Cohen, D., and Harley, C. B. (1993) Loss of telomeric DNA during aging of normal and trisomy 21 human lymphocytes. Am. J. Hum. Genet. 52, 661-667.
111. Vulliamy, T. J., Knight, S. W., Mason, P. J., and Dokal, I. (2001a) Very short telomeres in the peripheral blood of patients with X-linked and autosomal dyskeratosis congenita. Blood Cells Mol. Dis. 27, 353-357.
112. Vulliamy, T., Marrone, A., Goldman, F., Dearlove, A., Bessler, M., Mason, P. J., and Dokal, I. (2001b) The RNA component of telomerase is mutated in autosomal dominant dyskeratosis congenita. Nature 413, 432-435.
113. Vulliamy, T., Marrone, A., Dokal, I., and Mason, P. J. (2002) Association between aplastic anaemia and mutations in telomerase RNA. Lancet 359, 2168-2170.
114. Wege, H., Le, H. T., Chui, M. S., Liu, L., Wu, J., Giri, R., Malhi, H., Sappal, B. S., Kumaran, V, Gupta, S., and Zern, M. A. (2003) Telomerase reconstitution immortalizes human fetal hepatocytes without disrupting their differentiation potential. Gastroenterology 124, 432-444.
115. Weng, N. P., Granger, L., and Hodes, R. J. (1997) Telomere lengthening and telomerase activation during human B cell differentiation. Proc. Natl. Acad. Sci. USA 94, 10827-10832.
116. Wiemann, S. U., Satyanarayana, A., Tsahuridu, M., Tillmann, H. L., Zender, L., Klempnauer, J., Flemming, P., Franco, S., Blasco, M. A., Manns, M. P., and Rudolph, K. L. (2002) Hepatocytes telomerc shortening and senescence are general marker of human liver cirrhosis. FASEB J. 16, 935-942.
117. Wolthers, K. C., Noest, A. J., Otto, S. A., Miedema, F., and De Boer, R. J. (1999) Normal telomere lengths in naïve and memory CD4+ T cells in HIV type 1 infection: a mathematical interpretation. AIDS Res. Hum. Retroviruses 15, 1053-1062.
118. Wong, K. K., Maser, R. S., Bachoo, R. M., Menon, J., Carrasco, D. R., Gu, Y., Alt, F. W., and DePinho, R. A. (2003) Telomere dysfunction and Atm deficiency compromises organ homeostasis and accelerates ageing. Nature 421, 643-648.
119. Wright, W. E. and Shay, J. W. (1992) The two stage mechanism controlling cellular senescence and immortalization. Exp. Gerontol. 27, 389.
120. Wright, W. E. and Shay, J. W. (2001) Cellular senescence as a tumor-protection mechanism: the essential role of counting. Crit. Opin. Genet. Dev. 11, 98-103.
121. Wright, W. E., Piatyszek, M. A., Rainey, W. E., Byrd, W., and Shay, J. W. (1996) Telomerase activity in human germline and embryonic tissue and cells. Dev. Genet. 18, 173-179.
122. Wu, K. J., Grandori, C., Amacker, M., Simon-Vermot, N., Polack, A., Lingner, J., and Dalla-Favera, R. (1999) Direct activation of TERT transcription by c-MYC. Nat. Genet. 21, 220-224.
123. Wu, L. and Hickson, I. D. (2001) Molecular biology: enhanced: DNA ends ReQ-uire attention. Science 292, 229-230.
124. Wyllie, F. S., Jones, C. J., Skinner, J. W., Haughton, M. F., Wallis, C., Wynford-Thomas, D., Faragher, R. G., and Kipling, D. (2000) Telomerase prevents the accelerated cell ageing of Werner syndrome fibroblasts. Nat. Genet. 24, 16-17.
125. Xu, D., Gruber, A., Peterson, C., and Pisa, P. (1998) Telomerase activity and the expression of telomerase components in acute myelogenous leukaemia. Br. J. Haematol. 102, 1367-1375.
126. Yang, J., Chang, E., Cherry, A. M., Bangs, C. D., Oei, Y., Bodnar, A., Bronstein, A., Chiu, C. P., and Herron, G. S. (1999) Human endothelial cell life extension by telomerase expression. J. Biol. Chem. 274, 26141-26148.
127. Yang, L., Suwa, T., Wright, W. E., Shay, J. W., and Hornsby, P. J. (2001) Telomere shortening and decline in replicative potential as a function of donor age in human adrenocortical cells. Mech. Ageing Dev. 122, 1685-1694.
128. Zhang, A., Zheng, C., Hou, M., Lindvall, C., Li, K. J., Erlandson, F., Bjorkholm, M., Gruber, A., Blennow, E., and Xu, D. (2003) Deletion of the telomerase reverse transcriptase gene and haploinsufficiency of telomere maintenance in Cri du Chat Syndrome. Am. J. Hum. Genet. 72, (in press).
129. Zeichner, S. L., Palumbo, P., Feng, Y., Xiao, X., Gee, D., Sleasman, J., Goodenow, M., Biggar, R., and Dimitrov, D. (1999) Rapid telomere shortening in children. Blood 93, 2824-2830.